1. Home
  2. HWM vs REGN Comparison

HWM vs REGN Comparison

Compare HWM & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Howmet Aerospace Inc.

HWM

Howmet Aerospace Inc.

N/A

Current Price

$220.17

Market Cap

91.6B

Sector

Industrials

ML Signal

N/A

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$959.80

Market Cap

84.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HWM
REGN
Founded
1888
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6B
84.3B
IPO Year
2005
1995

Fundamental Metrics

Financial Performance
Metric
HWM
REGN
Price
$220.17
$959.80
Analyst Decision
Strong Buy
Buy
Analyst Count
22
28
Target Price
$296.29
★ $977.93
AVG Volume (30 Days)
★ 3.7M
900.8K
Earning Date
10-29-2026
10-30-2026
Dividend Yield
0.25%
★ 0.40%
EPS Growth
★ 32.03
8.19
EPS
4.18
★ 37.37
Revenue
N/A
★ $5,872,227,000.00
Revenue This Year
$24.86
$30.96
Revenue Next Year
$13.49
$7.28
P/E Ratio
$53.25
★ $25.47
Revenue Growth
N/A
★ 20.82
52 Week Low
$183.52
$591.52
52 Week High
$310.00
$991.73

Technical Indicators

Market Signals
Indicator
HWM
REGN
Relative Strength Index (RSI) 53.38 68.51
Support Level $183.52 $747.82
Resistance Level $229.57 $991.73
Average True Range (ATR) 8.74 36.53
MACD 3.20 5.40
Stochastic Oscillator 84.84 81.08

Price Performance

Historical Comparison
HWM
REGN

About HWM Howmet Aerospace Inc.

Howmet Aerospace Inc offers engineered solutions for the aerospace and transportation industries. The company's products and solutions include investment castings for jet engines and industrial gas turbines; seamless rolled rings for jet engines; fastening systems for aerospace, industrial and commercial transportation applications; forged jet engine components (e.g., jet engine disks); machined and forged aircraft parts; and forged aluminum commercial vehicle wheels, all of which are sold directly to customers or through distributors. It has four reportable segments: Engine Products, which derives key revenue, Fastening Systems, Engineered Structures, and Forged Wheels. Geographically, the company derives maximum revenue from the USA, followed by France, Japan, Germany, and other markets.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: